All Curated Mutation Sites in HIV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Keyword: HIV Infections-31683782

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	31683782	D62E	Env	Env	HIV Infections	G R S L	View
2	31683782	D751V	Env	Env	HIV Infections	G R S L	View
3	31683782	F717F	Env	Env	HIV Infections	G R S L	View
4	31683782	F717L	Env	Env	HIV Infections	G R S L	View
5	31683782	G514T	Env	Env	HIV Infections	G R S L	View
6	31683782	I154M	Env	Env	HIV Infections	G R S L	View
7	31683782	I360V	Env	Env	HIV Infections	G R S L	View
8	31683782	K33Q	Env	Env	HIV Infections	G R S L	View
9	31683782	L464N	Env	Env	HIV Infections	G R S L	View
10	31683782	M24I	Env	Env	HIV Infections	G R S L	View
11	31683782	Q621D	Env	Env	HIV Infections	G R S L	View
12	31683782	R737T	Env	Env	HIV Infections	G R S L	View
13	31683782	R744R	Env	Env	HIV Infections	G R S L	View
14	31683782	R744T	Env	Env	HIV Infections	G R S L	View
15	31683782	R747R	Env	Env	HIV Infections	G R S L	View
16	31683782	R841I	Env	Env	HIV Infections	G R S L	View
17	31683782	R841L	Env	Env	HIV Infections	G R S L	View

Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.